CalciMedica
CALC
24 hedge funds and large institutions have $13.6M invested in CalciMedica in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
15% more capital invested
Capital invested by funds: $11.8M → $13.6M (+$1.78M)
14% more funds holding
Funds holding: 21 → 24 (+3)
0.82% more ownership
Funds ownership: 27.67% → 28.49% (+0.82%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
CALC Hedge Fund Activity: Q3 2024 in Review
24 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2024, worth a combined $13.6M — up 15% from $11.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CALC positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $99K. The largest seller was BML Capital Management, cutting an estimated $28.7K.
- 24 institutional investors held CalciMedica (CALC) as of Q3 2024, up from 21 in Q2 2024.
- Funds reported $13.6M of CalciMedica stock for Q3 2024, up 15% quarter-over-quarter.
- 5 funds opened new CalciMedica positions in Q3 2024 and 2 closed out, a net change of +3 holders.
- The largest CalciMedica buyer in Q3 2024 was Geode Capital Management, an estimated $99K added.
- The largest CalciMedica seller in Q3 2024 was BML Capital Management, an estimated $28.7K sold.
Based on aggregated 13F filings for Q3 2024.